StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Oncore

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Jul 06, 2021 12:10am

101 Views

Post# 33497409

RE:Oncore

Here comes Liked2Lie again, counting on your laziness to convince you of his lies. Either that, or he simply doesn't understand the basics of corporate structure...

https://oncorepharma.com/distributors/

What a maroon!

Liked2Think wrote: https://oncorepharma.com/oncore-pharma-signs-a-multi-year-agreement-valued-at-61-8-million/

I cant even find that "place holder" website of ibodycheck or whatever it was now.

Yes covid happened but your telling me this $61.8M contract was real? Still no BodyCheck website exists that I can find.

Yet not 1 penny of it has been achieved or mentioned since. Its been over a year and a half and this is the last news on oncore.

Does anyone believe any of these 'deals" were real now?